Access the full text.
Sign up today, get DeepDyve free for 14 days.
A. Warren, H. Brorson, L. Borud, S. Slavin (2007)
Lymphedema: A Comprehensive ReviewAnnals of Plastic Surgery, 59
Inho Choi, Sunju Lee, Hee Chung, Yong Lee, Kyu Kim, Dongwon Choi, Eunkyung Park, Dongyun Yang, Tatiana Ecoiffier, J. Monahan, Wen Chen, B. Aguilar, Ha Lee, Jaehyuk Yoo, C. Koh, Lu Chen, Alex Wong, Young-Kwon Hong (2012)
9-Cis Retinoic Acid Promotes Lymphangiogenesis and Enhances Lymphatic Vessel Regeneration: Therapeutic Implications of 9-Cis Retinoic Acid for Secondary LymphedemaCirculation, 125
T. Tammela, K. Alitalo (2010)
Lymphangiogenesis: Molecular Mechanisms and Future PromiseCell, 140
K. Kajiya, S. Hirakawa, B. Ma, Ines Drinnenberg, M. Detmar (2005)
Hepatocyte growth factor promotes lymphatic vessel formation and functionThe EMBO Journal, 24
M. Dyer (2003)
The Homeodomain Proteins Prox1, Six3 and Chx10 Regulate Proliferation, Cell Fate Specification and Differentiation in the Developing RetinaCell Cycle, 2
S. Starckx, A. Wuyts, Inge Opsomer, E. Coillie, P. Proost, B. Arnold, J. Damme, G. Opdenakker (2002)
Recombinant mouse granulocyte chemotactic protein-2: production in bacteria, characterization, and systemic effects on leukocytes.Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research, 22 9
M. Caunt, Judy Mak, Wei-Ching Liang, S. Stawicki, Q. Pan, Raymond Tong, J. Kowalski, Calvin Ho, H. Reslan, J. Ross, L. Berry, I. Kasman, C. Zlot, Zhiyong Cheng, Jennifer Couter, E. Filvaroff, G. Plowman, F. Peale, D. French, R. Carano, A. Koch, Yan Wu, R. Watts, M. Tessier-Lavigne, A. Bagri (2008)
Blocking neuropilin-2 function inhibits tumor cell metastasis.Cancer cell, 13 4
R. Cao, Sharon Lim, H. Ji, Yin Zhang, Yunlong Yang, J. Honek, E. Hedlund, Yihai Cao (2011)
Mouse corneal lymphangiogenesis modelNature Protocols, 6
R. Vassar, M. Rosenberg, S. Ross, A. Tyner, E. Fuchs (1989)
Tissue-specific and differentiation-specific expression of a human K14 keratin gene in transgenic mice.Proceedings of the National Academy of Sciences of the United States of America, 86 5
A. Logan (1993)
AngiogenesisThe Lancet, 341
J. Rutkowski, M. Moya, J. Johannes, J. Goldman, M. Swartz (2006)
Secondary lymphedema in the mouse tail: Lymphatic hyperplasia, VEGF-C upregulation, and the protective role of MMP-9.Microvascular research, 72 3
Young-Kwon Hong, B. Lange‐Asschenfeldt, P. Velasco, S. Hirakawa, R. Kunstfeld, L. Brown, P. Bőhlen, D. Senger, M. Detmar (2004)
VEGF-A promotes tissue repair-associated lymphatic vessel formation via VEGFR-2 and the alpha1beta1 and alpha2beta1 integrins.FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 18 10
X. Wang, S. Zinkel, K. Polonsky, E. Fuchs (1997)
Transgenic studies with a keratin promoter-driven growth hormone transgene: prospects for gene therapy.Proceedings of the National Academy of Sciences of the United States of America, 94 1
A. Koch, P. Polverini, S. Kunkel, L. Harlow, L. DiPietro, V. Elner, S. Elner, R. Strieter (1992)
Interleukin-8 as a macrophage-derived mediator of angiogenesis.Science, 258 5089
KH Schmitz (2012)
Prevalence of breast cancer treatment sequelae over 6 years of follow-up: the pulling through studyCancer, 118
Meit Björndahl, R. Cao, L. Nissen, S. Clasper, L. Johnson, Yuan Xue, Zhongjun Zhou, D. Jackson, Anker Hansen, Yihai Cao (2005)
Insulin-like growth factors 1 and 2 induce lymphangiogenesis in vivoProceedings of the National Academy of Sciences of the United States of America, 102
J. Petrek, R. Senie, M. Peters, P. Rosen (2001)
Lymphedema in a cohort of breast carcinoma survivors 20 years after diagnosisCancer, 92
T. Petrova, T. Mäkinen, T. Mäkelä, J. Saarela, I. Virtanen, R. Ferrell, D. Finegold, D. Kerjaschki, S. Ylä-Herttuala, K. Alitalo (2002)
Lymphatic endothelial reprogramming of vascular endothelial cells by the Prox‐1 homeobox transcription factorThe EMBO Journal, 21
Young-Kwon Hong, B. Lange‐Asschenfeldt, P. Velasco, S. Hirakawa, R. Kunstfeld, L. Brown, P. Bőhlen, D. Senger, M. Detmar (2004)
VEGF‐A promotes tissue repair‐associated lymphatic vessel formation via VEGFR‐2 and the α1β1 and α2β1 integrinsThe FASEB Journal, 18
D. Waugh, Catherine Wilson (2008)
The Interleukin-8 Pathway in CancerClinical Cancer Research, 14
J. White, Judithann Lee, P. Young, R. Hertzberg, A. Jurewicz, M. Chaikin, K. Widdowson, J. Foley, L. Martin, D. Griswold, H. Sarau (1998)
Identification of a Potent, Selective Non-peptide CXCR2 Antagonist That Inhibits Interleukin-8-induced Neutrophil Migration*The Journal of Biological Chemistry, 273
H. Shimoda, M. Bernas, M. Witte (2011)
Dysmorphogenesis of lymph nodes in Foxc2 haploinsufficient miceHistochemistry and Cell Biology, 135
Jay Shin, Michael Min, Frédéric Larrieu-Lahargue, X. Canron, R. Kunstfeld, Lynh Nguyen, J. Henderson, A. Bikfalvi, M. Detmar, Young-Kwon Hong (2005)
Prox1 promotes lineage-specific expression of fibroblast growth factor (FGF) receptor-3 in lymphatic endothelium: a role for FGF signaling in lymphangiogenesis.Molecular biology of the cell, 17 2
Tatiana Ecoiffier, Don Yuen, Lu Chen (2010)
Differential distribution of blood and lymphatic vessels in the murine cornea.Investigative ophthalmology & visual science, 51 5
M. Dyer, F. Livesey, C. Cepko, G. Oliver (2003)
Prox1 function controls progenitor cell proliferation and horizontal cell genesis in the mammalian retinaNature Genetics, 34
C. Shah, F. Vicini (2011)
Breast cancer-related arm lymphedema: incidence rates, diagnostic techniques, optimal management and risk reduction strategies.International journal of radiation oncology, biology, physics, 81 4
N. Banziger-Tobler, C. Halin, K. Kajiya, M. Detmar (2008)
Growth hormone promotes lymphangiogenesis.The American journal of pathology, 173 2
J. Nagy, E. Vasile, Dian Feng, C. Sundberg, L. Brown, E. Manseau, A. Dvorak, H. Dvorak (2002)
VEGF-A induces angiogenesis, arteriogenesis, lymphangiogenesis, and vascular malformations.Cold Spring Harbor symposia on quantitative biology, 67
J. Kang, Jaehyuk Yoo, Sunju Lee, Wanli Tang, B. Aguilar, Swapnika Ramu, Inho Choi, Hasan Otu, Jay Shin, G. Dotto, Chester Koh, M. Detmar, Young-Kwon Hong (2010)
An exquisite cross-control mechanism among endothelial cell fate regulators directs the plasticity and heterogeneity of lymphatic endothelial cells.Blood, 116 1
A. Simonini, M. Moscucci, D. Muller, E. Bates, F. Pagani, M. Burdick, R. Strieter (2000)
IL-8 is an angiogenic factor in human coronary atherectomy tissue.Circulation, 101 13
F. Bos, M. Caunt, J. Peterson-Maduro, L. Planas-Paz, J. Kowalski, Terhi Karpanen, A. Impel, Raymond Tong, J. Ernst, J. Korving, J. Es, E. Lammert, H. Duckers, S. Schulte-Merker (2011)
CCBE1 Is Essential for Mammalian Lymphatic Vascular Development and Enhances the Lymphangiogenic Effect of Vascular Endothelial Growth Factor-C In VivoCirculation Research, 109
Shannon Baxter, D. Cheung, P. Bocangel, H. Kim, Krista Herbert, Josette Douville, Jaganmohan Jangamreddy, Shunzhen Zhang, D. Eisenstat, J. Wigle (2011)
Regulation of the lymphatic endothelial cell cycle by the PROX1 homeodomain protein.Biochimica et biophysica acta, 1813 1
C. Murdoch, P. Monk, Adam Finn (1999)
Cxc chemokine receptor expression on human endothelial cells.Cytokine, 11 9
Hui Zhang, Xuemei Hu, J. Tse, Firehiwott Tilahun, M. Qiu, Lu Chen (2011)
Spontaneous lymphatic vessel formation and regression in the murine cornea.Investigative ophthalmology & visual science, 52 1
Sunju Lee, J. Kang, Jaehyuk Yoo, S. Ganesan, S. Cook, B. Aguilar, Swapnika Ramu, Juneyong Lee, Young-Kwon Hong (2009)
Prox1 physically and functionally interacts with COUP-TFII to specify lymphatic endothelial cell fate.Blood, 113 8
R. Kunstfeld, S. Hirakawa, Young-Kwon Hong, V. Schacht, B. Lange‐Asschenfeldt, P. Velasco, Charles Lin, E. Fiebiger, Xunbin Wei, Yan Wu, D. Hicklin, P. Bőhlen, M. Detmar (2004)
Induction of cutaneous delayed-type hypersensitivity reactions in VEGF-A transgenic mice results in chronic skin inflammation associated with persistent lymphatic hyperplasia.Blood, 104 4
Carmen Bozic, Norma Gerard, C. Uexkull-Guldenband, Lee Kolakowski, M. Conklyn, R. Breslow, H. Showell, Craig Gerard (1994)
The murine interleukin 8 type B receptor homologue and its ligands. Expression and biological characterization.The Journal of biological chemistry, 269 47
Joel Nelson, O. Denisenko, K. Bomsztyk (2006)
Protocol for the fast chromatin immunoprecipitation (ChIP) methodNature Protocols, 1
K. Kubo, Toshiyuki Shimizu, Shin-ichi Ohyama, Hideko Murooka, A. Iwai, Kazuhide Nakamura, Kazumasa Hasegawa, Yoshiko Kobayashi, N. Takahashi, Kazumi Takahashi, S. Kato, T. Izawa, T. Isoe (2005)
Novel potent orally active selective VEGFR-2 tyrosine kinase inhibitors: synthesis, structure-activity relationships, and antitumor activities of N-phenyl-N'-{4-(4-quinolyloxy)phenyl}ureas.Journal of medicinal chemistry, 48 5
J. Wigle, K. Chowdhury, P. Gruss, G. Oliver (1999)
Prox1 function is crucial for mouse lens-fibre elongationNature Genetics, 21
Camilla Norrmén, T. Tammela, T. Petrova, K. Alitalo (2011)
Biological Basis of Therapeutic LymphangiogenesisCirculation, 123
Aihua Li, S. Dubey, M. Varney, B. Dave, Rakesh Singh (2003)
IL-8 Directly Enhanced Endothelial Cell Survival, Proliferation, and Matrix Metalloproteinases Production and Regulated Angiogenesis1The Journal of Immunology, 170
J. Barlic, P. Murphy (2007)
Chemokine regulation of atherosclerosisJournal of Leukocyte Biology, 82
G. Oliver, K. Alitalo (2005)
The lymphatic vasculature: recent progress and paradigms.Annual review of cell and developmental biology, 21
S. Mclaughlin (2012)
Lymphedema: separating fact from fiction.Oncology, 26 3
R. Cao, Meit Björndahl, P. Religa, S. Clasper, Stina Garvin, D. Galter, B. Meister, F. Ikomi, K. Tritsaris, S. Dissing, T. Ohhashi, D. Jackson, Yihai Cao (2004)
PDGF-BB induces intratumoral lymphangiogenesis and promotes lymphatic metastasis.Cancer cell, 6 4
S. Hirakawa, Young-Kwon Hong, N. Harvey, V. Schacht, K. Matsuda, T. Libermann, M. Detmar (2003)
Identification of vascular lineage-specific genes by transcriptional profiling of isolated blood vascular and lymphatic endothelial cells.The American journal of pathology, 162 2
J. Nagy, E. Vasile, Dian Feng, C. Sundberg, L. Brown, M. Detmar, J. Lawitts, L. Benjamin, X. Tan, E. Manseau, A. Dvorak, H. Dvorak (2002)
Vascular Permeability Factor/Vascular Endothelial Growth Factor Induces Lymphangiogenesis as well as AngiogenesisThe Journal of Experimental Medicine, 196
Daniel Martin, Rebeca Galisteo, J. Gutkind (2009)
CXCL8/IL8 Stimulates Vascular Endothelial Growth Factor (VEGF) Expression and the Autocrine Activation of VEGFR2 in Endothelial Cells by Activating NFκB through the CBM (Carma3/Bcl10/Malt1) Complex*Journal of Biological Chemistry, 284
H. Mu, T. Calderone, M. Davies, V. Prieto, Hua Wang, G. Mills, M. Bar‐eli, J. Gershenwald (2012)
Lysophosphatidic acid induces lymphangiogenesis and IL-8 production in vitro in human lymphatic endothelial cells.The American journal of pathology, 180 5
M. Dyer (2003)
Regulation of proliferation, cell fate specification and differentiation by the homeodomain proteins Prox1, Six3, and Chx10 in the developing retina.Cell cycle, 2 4
H. Kubo, R. Cao, Ebba Bräkenhielm, T. Mäkinen, Yihai Cao, K. Alitalo (2002)
Blockade of vascular endothelial growth factor receptor-3 signaling inhibits fibroblast growth factor-2-induced lymphangiogenesis in mouse corneaProceedings of the National Academy of Sciences of the United States of America, 99
Su‐Ja Oh, Su‐Ja Oh, Markku Jeltsch, R. Birkenhäger, J. McCarthy, H. Weich, Bodo Christ, K. Alitalo, J. Wilting (1997)
VEGF and VEGF-C: specific induction of angiogenesis and lymphangiogenesis in the differentiated avian chorioallantoic membrane.Developmental biology, 188 1
Rosemarie Hardin, L. Jacobs (2012)
Lymphedema: still a problem without an answer.Oncology, 26 3
Young-Kwon Hong, N. Harvey, Y. Noh, V. Schacht, S. Hirakawa, M. Detmar, G. Oliver (2002)
Prox1 is a master control gene in the program specifying lymphatic endothelial cell fateDevelopmental Dynamics, 225
Mei-Ren Pan, Tsung-Ming Chang, Hui‐Chiu Chang, J. Su, Hsei-Wei Wang, W. Hung (2009)
Sumoylation of Prox1 controls its ability to induce VEGFR3 expression and lymphatic phenotypes in endothelial cellsJournal of Cell Science, 122
V. Kirkin, W. Thiele, P. Baumann, Ralph Mazitschek, K. Rohde, G. Fellbrich, H. Weich, J. Waltenberger, A. Giannis, J. Sleeman (2004)
MAZ51, an indolinone that inhibits endothelial cell and tumor cell growth in vitro, suppresses tumor growth in vivoInternational Journal of Cancer, 112
K. Schmitz, R. Speck, Sheree Rye, T. DiSipio, S. Hayes (2012)
Prevalence of breast cancer treatment sequelae over 6 years of follow‐upCancer, 118
S. Nakao, K. Maruyama, S. Zandi, M. Melhorn, M. Taher, K. Noda, Eyad Nusayr, T. Doetschman, Hafezi‐Moghadam Ali (2010)
Lymphangiogenesis and angiogenesis: concurrence and/or dependence? Studies in inbred mouse strainsThe FASEB Journal, 24
R. Strieter, S. Kunkel, V. Elner, C. Mártonyi, A. Koch, P. Polverini, S. Elner (1992)
Interleukin-8. A corneal factor that induces neovascularization.The American journal of pathology, 141 6
Inho Choi, H. Chung, Swapnika Ramu, Ha Lee, K. Kim, Sunju Lee, Jaehyuk Yoo, Dongwon Choi, Yong Lee, B. Aguilar, Young-Kwon Hong (2011)
Visualization of lymphatic vessels by Prox1-promoter directed GFP reporter in a bacterial artificial chromosome-based transgenic mouse.Blood, 117 1
Lymphedema is mainly caused by lymphatic obstruction and manifested as tissue swelling, often in the arms and legs. Lymphedema is one of the most common post-surgical complications in breast cancer patients and presents a painful and disfiguring chronic illness that has few treatment options. Here, we evaluated the therapeutic potential of interleukin (IL)-8 in lymphatic regeneration independent of its pro-inflammatory activity. We found that IL-8 promoted proliferation, tube formation, and migration of lymphatic endothelial cells (LECs) without activating the VEGF signaling. Additionally, IL-8 suppressed the major cell cycle inhibitor CDKN1C/p57KIP2 by downregulating its positive regulator PROX1, which is known as the master regulator of LEC-differentiation. Animal-based studies such as matrigel plug and cornea micropocket assays demonstrated potent efficacy of IL-8 in activating lymphangiogenesis in vivo. Moreover, we have generated a novel transgenic mouse model (K14-hIL8) that expresses human IL-8 in the skin and then crossed with lymphatic-specific fluorescent (Prox1-GFP) mouse. The resulting double transgenic mice showed that a stable expression of IL-8 could promote embryonic lymphangiogenesis. Moreover, an immunodeficient IL-8-expressing mouse line that was established by crossing K14-hIL8 mice with athymic nude mice displayed an enhanced tumor-associated lymphangiogenesis. Finally, when experimental lymphedema was introduced, K14-hIL8 mice showed an improved amelioration of lymphedema with an increased lymphatic regeneration. Together, we report that IL-8 can activate lymphangiogenesis in vitro and in vivo with a therapeutic efficacy in post-surgical lymphedema.
Angiogenesis – Springer Journals
Published: Sep 4, 2012
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.